Diminazene aceturate - An antiparasitic drug of antiquity: Advances in pharmacology & therapeutics

Pharmacological Research

Volumn 102, Issue , 2015, Pages 138-157

  Da Silva Oliveira, George Laylson ^a   De Freitas, Rivelilson Mendes ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Antitrypanosomal activity; Diamidine; Diminazene aceturate; Pharmacological properties; Trypanosomiasis

Indexed keywords

1 [(2 DIETHYLAMINO)ETHYLAMINO] 4 (HYDROXYMETHYL) 7 [(4 METHYLPHENYL)SULFONYLOXY] 9H XANTHENE 9 ONE; 4',6 DIAMIDINO 2 PHENYLINDOLE; ACID SENSING ION CHANNEL; ACID SENSING ION CHANNEL 1A; ACID SENSING ION CHANNEL 1B; ACID SENSING ION CHANNEL 2A; ACID SENSING ION CHANNEL 3; ALLICIN; AMILORIDE; AMPHOTERICIN B; ANGIOTENSIN CONVERTING ENZYME 2; ARTEMISONE; ARTESUNATE; ATOVAQUONE; CAMPTOTHECIN DERIVATIVE; COTRIMOXAZOLE; DIAMIDINE DERIVATIVE; DIMINAZENE ACETURATE; EFLORNITHINE; EPOXOMICIN; FUSIDIC ACID; HYDROXYSTILBAMIDINE; MILTEFOSINE; NEROLIDOL; PENTAMIDINE; PENTAMIDINE ISETHIONATE; TEA TREE OIL; TRIFLURALIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHENE DERIVATIVE; ANTIPARASITIC AGENT; DIMINAZENE;

ABDOMINAL AORTA ANEURYSM; ANTHELMINTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; BRAIN ISCHEMIA; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TARGETING; DRUG TOLERABILITY; ENZYME ACTIVATION; ERECTILE DYSFUNCTION; GLAUCOMA; HEART INFARCTION; HUMAN; IC50; IMMUNOMODULATION; LEISHMANIASIS; METABOLIC DISORDER; MONOTHERAPY; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PIROPLASMOSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPEATED DRUG DOSE; REVIEW; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; SKIN LEISHMANIASIS; SYSTEMATIC REVIEW; TRYPANOSOMA BRUCEI; TRYPANOSOMA CONGOLENSE; TRYPANOSOMA EVANSI; TRYPANOSOMA VIVAX; TRYPANOSOMIASIS; UNSPECIFIED SIDE EFFECT; UVEITIS; ANALOGS AND DERIVATIVES; ANIMAL;

ANIMALS; ANTIPARASITIC AGENTS; DIMINAZENE; HUMANS; TRYPANOSOMIASIS;

EID: 84944412290     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.10.005     Document Type: Review

References (137)

1. E. Scholar Diminazene B.B. David, xPharm: The Comprehensive Pharmacology Reference 2009 Elsevier New York 1 4
2. M.M., Hochst, Basic diazoaminobenzene compounds. US2673197 (1954).
3. C. Atsriku, D.G. Watson, J.N.A. Tettey, M.H. Grant, and G.G. Skellern Determination of diminazene aceturate in pharmaceutical formulations by HPLC and identification of related substances by LC/MS J. Pharm. Biomed. Anal. 30 2002 979 986
4. H.P. de Koning, L.F. Anderson, M. Stewart, R.J.S. Burchmore, L.J.M. Wallace, and M.P. Barrett The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in African trypanosomes Antimicrob. Agents Chemother. 48 2004 1515 1519
5. T. Čimbora-Zovko, A. Brozovic, I. Piantanida, G. Fritz, A. Virag, B. Alič, V. Majce, M. Kočevar, S. Polanc, and M. Osmak Synthesis and biological evaluation of 4-nitro-substituted 1,3-diaryltriazenes as a novel class of potent antitumor agents Eur. J. Med. Chem. 46 2011 2971 2983
6. R., Brodersen, Readily soluble and stable salts of di, US 2838485 A (1958).
7. B. Rotureau Through the dark continent: African trypanosome developments in the tsetse fly Front Cell Infect Microbiol. 18 2013 3 53
8. H.J. Vial, and A. Gorenflot Chemotherapy against babesiosis Vet. Parasitol. 138 2006 147 160
9. S. Gohil, S. Herrmann, S. Günther, and B.M. Cooke Bovine babesiosis in the 21st century: advances in biology and functional genomics Int. J. Parasitol. 43 2013 125 132
10. R.A. Joshua, M.J. Obwolo, O. Bwangamoi, and E. Mandebvu Resistance to diminazine aceturate by Trypanosoma congolense from cattle in the Zambezi Valley of Zimbabwe Vet. Parasitol. 60 1995 1 6
11. T.N. Egbe-Nwiyi, I.O. Igbokwe, and P.A. Onyeyili The pathogenicity of diminazene aceturate-resistant Trypanosoma brucei in rats after treatment with the drug J. Comp. Pathol. 128 2003 188 191
12. Y. Moti, R. De Deken, E. Thys, J. Van Den Abbeele, L. Duchateau, and V. Delespaux PCR and microsatellite analysis of diminazene aceturate resistance of bovine trypanosomes correlated to knowledge, attitude and practice of livestock keepers in South-Western Ethiopia Acta Trop. 146 2015 45 52
13. ®) on the pathology of experimental Trypanosoma brucei infection in red fronted gazelles (Gazella rufifrons) Vet. Parasitol. 163 2009 140 143
14. A.A. Tonin, A.S. Da Silva, M.M. Costa, M.A. Otto, G.R. Thomé, K.S. Tavares, L.C. Miletti, M.R. Leal, S.T.A. Lopes, C.M. Mazzanti, S.G. Monteiro, and M.L. de La Rue Diminazene aceturate associated with sodium selenite and vitamin E in the treatment of Trypanosoma evansi infection in rats Exp. Parasitol. 128 2011 243 249
15. A.S.M. Peregrineand, and n Mamma Pharmacology of diminazene: a review Acta Trop. 54 1993 185 203
16. S. Kuriakose, and J.E. Uzonna Diminazene aceturate (Berenil), a new use for an old compound? Int. Immunopharmacol. 21 2014 342 345
17. P. Mäser, A. Lüscher, and R. Kaminsky Drug transport and drug resistance in African trypanosomes Drug Resist. Updates 6 2003 281 290
18. S. Kuriakose, H.M. Muleme, C. Onyilagha, R. Singh, P. Jia, and J.E. Uzonna Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to trypanosoma congolense infection PLoS One 7 2012 e48696
19. A. Sow, I. Sidibé, Z. Bengaly, T. Marcotty, M. Séré, A. Diallo, H.S. Vitouley, R.L. Nebié, M. Ouédraogo, G.K. Akoda, P. Van den Bossche, J. Van Den Abbeele, R. De Deken, and V. Delespaux Field detection of resistance to isometamidium chloride and diminazene aceturate in Trypanosoma vivax from the region of the Boucle du Mouhoun in Burkina Faso Vet. Parasitol. 187 2012 105 111
20. V. Delespaux, and H.P. Koning Drugs and drug resistance in African trypanosomiasis Drug Resist. Updates 10 2007 30 50
21. C.F. Obi, R.I. Obidike, I.O. Ezeh, V.U. Omoja, C.N. Iheagwam, I.K. Idika, and R.C. Ezeokonkwo Effects of Trypanosoma brucei infection and diminazene aceturate therapy on testicular morphology and function of Nigerian local dogs Vet. Parasitol. 196 2013 283 288
22. D. Tuntasuvan, W. Jarabrum, N. Viseshakul, K. Mohkaew, S. Borisutsuwan, A. Theeraphan, and N. Kongkanjana Chemotherapy of surra in horses and mules with diminazene aceturate Vet. Parasitol. 110 2003 227 233
23. A.S. Da Silva, R.A. Zanette, P. Wolkmer, M.M. Costa, H.A. Garcia, S.T.A. Lopes, J.M. Santurio, M.M.G. Teixeira, and S.G. Monteiro Diminazene aceturate in the control of Trypanosoma evansi infection in cats Vet. Parasitol. 165 2009 47 50
24. W. Olaho-Mukani, W.K. Munyua, and A.R. Njogu Haemolytic complement and class-specific antibody levels in goats during infection with Trypanosoma evansi and after treatment with diminazene aceturate Small Rum. Res. 22 1996 241 247
25. R.S. Silayo, M. Mamman, S.K. Moloo, Y.O. Aliu, M.A. Gray, and A.S. Peregrine Response of Trypanosoma congolense in goats to single and double treatment with diminazene aceturate Res. Vet. Sci. 53 1992 98 105
26. A. Diack, S.K. Moloo, and A.S. Peregrine Effect of diminazene aceturate on the infectivity and transmissibility of drug-resistant Trypanosoma congolense in Glossina morsitans centralis Vet. Parasitol. 70 1997 13 23
27. R.E. Mdachi, G.A. Murilla, J.N. Omukuba, and V. Cagnolati Disposition of diminazene aceturate (Berenil®) in trypanosome-infected pregnant and lactating cows Vet. Parasitol. 58 1995 215 225
28. J.D. Maya, C.O. Salas, B. Aguilera-Venegas, M.V. Diaz, and R. Lopez-Munoz Key proteins in the polyamine-trypanothione pathway as drug targets against trypanosoma cruzi Curr. Med. Chem. 21 2014 1757 1771
29. S. Neidle DNA minor-groove recognition by small molecules Nat. Prod. Rep. 18 2001 291 309
30. J. Zhou, V. Le, D. Kalia, S. Nakayama, C. Mikek, E.A. Lewis, and H.O. Sintim Diminazene or berenil, a classic duplex minor groove binder, binds to G-quadruplexes with low nanomolar dissociation constants and the amidine groups are also critical for G-quadruplex binding Mol. Biosyst. 10 2014 2724 2734
31. C. Caramelo-Nunes, T. Tente, P. Almeida, J.C. Marcos, and C.T. Tomaz Specific berenil-DNA interactions: an approach for separation of plasmid isoforms by pseudo-affinity chromatography Anal. Biochem. 412 2011 153 158
32. T.A. Shapiro, and P.T. Englund Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs Proc. Natl. Acad. Sci. U. S. A. 87 1990 950 954
33. S. Watier-Grillot, S. Herder, J.-L. Marié, G. Cuny, and B. Davoust Chemoprophylaxis and treatment of African canine trypanosomosis in French military working dogs: a retrospective study Vet. Parasitol. 194 2013 1 8
34. A. Sahin, C. Asencio, J. Izotte, D. Pillay, V. Coustou, H. Karembe, and T. Baltz The susceptibility of Trypanosoma congolense and Trypanosoma brucei to isometamidium chloride and its synthetic impurities Vet. Parasitol. 203 2014 270 275
35. A.S. Da Silva, C. Tochetto, R.A. Zanette, F. Pierezan, D.R. Rissi, J.M. Santurio, and S.G. Monteiro Aceturato de diminazeno e dipropionato de imidocarb no controle de infecção por Trypanosoma evansi em Rattus norvegicus infectados experimentalmente Cienc. Rural. 38 2008 1357 1362
36. V. Delespaux, H. Dinka, J. Masumu, P. Van den Bossche, and S. Geerts Five-fold increase in Trypanosoma congolense isolates resistant to diminazene aceturate over a seven-year period in Eastern Zambia Drug Resist. Updates 11 2008 205 209
37. W.H. Witola, A. Tsuda, N. Inoue, K. Ohashi, and M. Onuma Acquired resistance to berenil in a cloned isolate of Trypanosoma evansi is associated with upregulation of a novel gene, TeDR40 Parasitology 131 2005 635 646
38. J.C. Munday, K.E. Rojas López, A.A. Eze, V. Delespaux, J. Van Den Abbeele, T. Rowan, M.P. Barrett, L.J. Morrison, and H.P. Koning Functional expression of TcoAT1 reveals it to be a P1-type nucleoside transporter with no capacity for diminazene uptake Int. J. Parasitol. Drugs Drug Resist. 3 2013 69 76
39. C.B. Oliveira, L.A. Rigo, L.D. Rosa, L.T. Gressler, C.E.P. Zimmermann, A.F. Ourique, A.S.D.A. Silva, L.C. Miletti, R.C.R. Beck, and S.G. Monteiro Liposomes produced by reverse phase evaporation: in vitro and in vivo efficacy of diminazene aceturate against Trypanosoma evansi Parasitology 141 2014 761 769
40. J.I. Ihedioha, I.S. Ochiogu, and T.E. Ihedioha Co-administration of Na-EDTA and Diminazene Aceturate (DA) to Mice Infected with DA-resistant Trypanosoma brucei J. Comp. Pathol. 136 2007 206 211
41. A.I. Chekwube, E.I. Onyema, U.E. Ikenna, and R.C. Ezeokonkwo Effect of diminazene aceturate, levamisole and vitamin C combination therapy in rats experimentally infected with Trypanosoma brucei brucei Asian Pac. J. Trop. Med. 7 2014 438 445
42. M.D. Baldissera, A.S. Da Silva, C.B. Oliveira, R.C.V. Santos, R.A. Vaucher, R.P. Raffin, P. Gomes, M.G.C. Dambros, L.C. Miletti, A.A. Boligon, M.L. Athayde, and S.G. Monteiro Trypanocidal action of tea tree oil (Melaleuca alternifolia) against Trypanosoma evansi in vitro and in vivo used mice as experimental model Exp. Parasitol. 141 2014 21 27
43. A. Nehrbass-Stuedli, D. Boykin, R.R. Tidwell, and R. Brun Novel diamidines with activity against babesia divergens in vitro and babesia microti in vivo Antimicrob. Agents Chemother. 55 2011 3439 3445
44. M.J. Yabsley, and B.C. Shock Natural history of Zoonotic Babesia: role of wildlife reservoirs Int. J. Parasitol. Parasites Wildl. 2 2013 18 31
45. P.J. Irwin Canine babesiosis Vet. Clin. North Am. Small Anim. Pract. 40 2010 1141 1156
46. A. Guswanto, T. Sivakumar, M.A. Rizk, S.A.E. Elsayed, M.A. Youssef, E.E.S. ElSaid, N. Yokoyama, and I. Igarashi Evaluation of a fluorescence-based method for antibabesial drug screening Antimicrob. Agents Chemother. 58 2014 4713 4717
47. S.P. Sharma, and G.C. Bansal Chemoprophylaxis with diminazene aceturate in experimental Babesia bigemina infection in cattle Res. Vet. Sci. 37 1984 126 127
48. H. Singh, N.K. Singh, N. Chand, S. Deshmukh, R.S. Jyoti, and S.S. Singh Concurrent infection of Babesia bigemina and Theileria annulata in Holstein Friesian cow: A case report J. Vet. Parasitol. 25 2011 82 83
49. H. Rashid, M. Chaudhry, H. Rashid, K. Pervez, M. Khan, and A. Mahmood Comparative efficacy of diminazene diaceturate and diminazene aceturate for the treatment of babesiosis in horses Trop. Anim. Health Prod. 40 2008 463 467
50. A. Birkenheuer, M. Levy, K. Savary, R. Gager, and E. Breitschwerdt Babesia gibsoni infections in dogs from North Carolina J. Am. Anim. Hosp. Assoc. 35 1999 125 128
51. M.G. Groves, and G.L. Dennis Babesia gibsoni: Field and laboratory studies of canine infections Exp. Parasitol. 31 1972 153 159
52. M. Konto, A.A. Biu, M.I. Ahmed, A.W. Mbaya, and J. Luka Clinico-biochemical responses of dogs to experimental infection with Babesia canis Vet. World 7 2014 113 118
53. S.J. Hwang, M. Yamasaki, K. Nakamura, N. Sasaki, M. Murakami, B.K. Wickramasekara Rajapakshage, H. Ohta, Y. Maede, and M. Takiguchi Development and characterization of a strain of Babesia gibsoni Resistant to Diminazene Aceturate In Vitro J. Vet. Med. Sci. 72 2010 765 771
54. B.K. Wickramasekara Rajapakshage, M. Yamasaki, S.-J. Hwang, N. Sasaki, M. Murakami, Y. Tamura, S.Y. Lim, K. Nakamura, H. Ohta, and M. Takiguchi Involvement of mitochondrial genes of Babesia gibsoni in resistance to Diminazene aceturate J. Vet. Med. Sci. 74 2012 1139 1148
55. B.K.W. Rajapakshage, M. Yamasaki, M. Murakami, Y. Tamura, S.Y. Lim, T. Osuga, N. Sasaki, K. Nakamura, H. Ohta, and M. Takiguchi Analysis of energy generation and glycolysis pathway in diminazene aceturate-resistant Babesia gibsoni isolate in vitro Jpn. J. Vet. Res. 60 2012 51 61
56. M.L. Mazuz, J. Golenser, L. Fish, R.K. Haynes, R. Wollkomirsky, B. Leibovich, and V. Shkap Artemisone inhibits in vitro and in vivo propagation of Babesia bovis and B. bigemina parasites Exp. Parasitol. 135 2013 690 694
57. M. AbouLaila, T. Sivakumar, N. Yokoyama, and I. Igarashi Inhibitory effect of terpene nerolidol on the growth of Babesia parasites Parasitol. Int. 59 2010 278 282
58. M. AbouLaila, K. Nakamura, Y. Govind, N. Yokoyama, and I. Igarashi Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites Vet. Parasitol. 167 2010 19 27
59. M.G. Silva, A. Domingos, M.A. Esteves, M.E.M. Cruz, and C.E. Suarez Evaluation of the growth-inhibitory effect of trifluralin analogues on in vitro cultured Babesia bovis parasites Int. J. Parasitol. Drugs Drug Resist. 3 2013 59 68
60. A. Matsuu, Y. Koshida, M. Kawahara, K. Inoue, H. Ikadai, Y. Hikasa, S. Okano, and S. Higuchi Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro Vet. Parasitol. 124 2004 9 18
61. M. Collett Survey of canine babesiosis in South Africa J. S. Afr. Vet. Assoc. 71 2000 180 186
62. A. Salama, M. AbouLaila, M. Terkawi, A. Mousa, A. El-Sify, M. Allaam, A. Zaghawa, N. Yokoyama, and I. Igarashi Inhibitory effect of allicin on the growth of Babesia and Theileria equi parasites Parasitol. Res. 113 2014 275 283
63. A.A. Salama, M. AbouLaila, A.A. Moussa, M.A. Nayel, A. El-Sify, M.A. Terkawi, H.Y. Hassan, N. Yokoyama, and I. Igarashi Evaluation of in vitro and in vivo inhibitory effects of fusidic acid on Babesia and Theileria parasites Vet. Parasitol. 191 2013 1 10
64. J.C. Miller, and D. Davis Increasing frequency of feline cytauxzoonosis cases diagnosed in western Kentucky from 2001 to 2011 Vet. Parasitol. 198 2013 205 208
65. C.E. Greene, K. Latimer, E. Hopper, G. Shoeffler, K. Lower, and F. Cullens Administration of diminazene aceturate or imidocarb dipropionate for treatment of cytauxzoonosis in cats J. Am. Vet. Med. Assoc. 215 1999 497 500
66. K.M. Lewis, L.A. Cohn, H.S. Marr, and A.J. Birkenheuer Diminazene diaceturate for treatment of chronic cytauxzoon felis parasitemia in naturally infected cats J. Vet. Intern. Med. 26 2012 1490 1493
67. K.M. Lewis, L.A. Cohn, H.S. Marr, and A.J. Birkenheuer Failure of efficacy and adverse events associated with dose-intense diminazene diaceturate treatment of chronic Cytauxzoon felis infection in five cats J. Feline Med. Surg. 16 2014 157 163
68. R. Balaña-Fouce, R. Álvarez-Velilla, C. Fernández-Prada, C. García-Estrada, and R.M. Reguera Trypanosomatids topoisomerase revisited. New structural findings and role in drug discovery Int. J. Parasitol. Drugs Drug Resist. 4 2014 326 337
69. A. Das, A. Dasgupta, T. Sengupta, and H.K. Majumder Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets Trends Parasitol. 20 2004 381 387
70. F. Poorrajab, S.K. Ardestani, A. Foroumadi, S. Emami, A. Kariminia, M. Behrouzi-Fardmoghadam, and A. Shafiee Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species Exp. Parasitol. 121 2009 323 330
71. C.F. Prada, R. Álvarez-Velilla, R. Balaña-Fouce, C. Prieto, E. Calvo-Álvarez, J.M. Escudero-Martínez, J.M. Requena, C. Ordóñez, A. Desideri, Y. Pérez-Pertejo, and R.M. Reguera Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect Biochem. Pharmacol. 85 2013 1433 1440
72. J. Mosqueda, A. Olvera-Ramirez, G. Aguilar-Tipacamu, and G.J. Canto Current advances in detection and treatment of Babesiosis Curr. Med. Chem. 19 2012 1504 1518
73. V. Jean-Moreno, R. Rojas, D. Goyeneche, G.H. Coombs, and J. Walker Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays Exp. Parasitol. 112 2006 21 30
74. A.Y. Chen, C. Yu, B. Gatto, and L.F. Liu DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors Proc. Natl. Acad. Sci. U. S. A. 90 1993 8131 8135
75. R. Mukhopadhyay, and R. Madhubal Antileishmanial activity of berenil and methylglyoxal bis (guanylhydrazone) and its correlation with S-adenosylmethionine decarboxylase and polyamines Int. J. Biochem. Cell Biol. 27 1995 55 59
76. E. Karvonen, L. Kauppinen, T. Partanen, and H. Pösö Irreversible inhibition of putrescine-stimulated S-adenosyl-L-methionine decarboxylase by berenil and pentamidine Biochem. J. 231 1985 165 169
77. R. Balan-a-Fouce, T.G. Pulido, D. Ordón-ez-Escudero, and A. Garrido-Pertierra Inhibition of diamine oxidase and S-adenosylmethionine decarboxylase by diminacene aceturate (berenil) Biochem. Pharmacol. 35 1986 1597 1600
78. W. Leon, R. Brun, and S.M. Krassner Effect of berenil on growth, mitochondrial DNA and respiration of Leishmania tarentolae Promastigotes∗ J. Protozool. 24 1977 444 448
79. J.M. Mutiso, J.C. Macharia, M. Barasa, E. Taracha, A.J. Bourdichon, and M.M. Gicheru In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice Rev. Inst. Med. Trop. Sao Paulo 53 2011 129 132
80. ®: a diminazene based drug as antileishmanial agent Acta Trop. 92 2004 267 272
81. L. Lynen, and W. Van Damme Local application of diminazene aceturate: an effective treatment for cutaneous leishmaniasis Ann. Soc. Belg. Med. Trop. 72 1992 13 19
82. E.G. Botterill, and G. Yi A rare survivor of Balamuthia granulomatous encephalitis Clin. Neurol. Neurosurg. 113 2011 499 502
83. J. Lorenzo-Morales, A.M. Cabello-Vílchez, C.M. Martín-Navarro, E. Martínez-Carretero, J.E. Piñero, and B. Valladares Is Balamuthia mandrillaris a public health concern worldwide? Trends Parasitol. 29 2013 483 488
84. A.F. Ahmad, W. Heaselgrave, P.W. Andrew, and S. Kilvington The in vitro efficacy of antimicrobial agents against the pathogenic free-living Amoeba Balamuthia mandrillaris J. Eukaryot Microbiol. 60 2013 539 543
85. J. Hay, C.M. Kirkness, D.V. Seal, and P. Wright Drug resistance and Acanthamoeba Keratitis: the quest for alternative antiprotozoal chemotherapy Eye 8 1994 555 563
86. T.J. Byers, B.G. Kim, L.E. King, and E.R. Hugo Molecular aspects of the cell cycle and encystment of Acanthamoeba Rev. Infect. Dis. 13 1991 S373 S384
87. S. Gupta, O.P. Shukla, and R.D. Walter Putrescine-activated S-adenosylmethionine decarboxylase from Acanthamoeba culbertsoni Mol. Biochem. Parasitol. 23 1987 247 252
88. E.R. Hugo, and T.J. Byers S-adenosyl-L-methionine decarboxylase of Acanthamoeba castellanii (Neff): purification and properties Biochem. J. 295 1993 203 209
89. A. Porollo, J. Meller, Y. Joshi, V. Jaiswal, A.G. Smulian, and M.T. Cushion Analysis of current antifungal agents and their targets within the Pneumocystis carinii Genome Curr. Drug Targets 13 2012 1575 1585
90. P.D. Walzer, C.K. Kim, J. Foy, M.J. Linke, and M.T. Cushion Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia Antimicrob. Agents Chemother. 32 1988 896 905
91. A.B. Clarkson, D.E. Williams, and C. Rosenberg Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia Antimicrob. Agents Chemother. 32 1988 1158 1163
92. C.M. Ferrario, S. Ahmad, J. Joyner, and J. Varagic Advances in the Renin Angiotensin System: Focus on Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) M.V. Paul, Advances in Pharmacology vol. 59 2010 Academic Press 197 233
93. A.J. Ferreira, M. Bader, and R.A. Santos Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review Expert Opin. Ther. Pat. 22 2012 567 574
94. C. Guang, R.D. Phillips, B. Jiang, and F. Milani Three key proteases-angiotensin-I-converting enzyme (ACE), ACE2 and reni-within and beyond the renin-angiotensin system Arch. Cardiovasc Dis. 105 2012 373 385
95. G. Foureaux, J.C. Nogueira, B.S. Nogueira, G.O. Fulgêncio, G.B. Menezes, S.O.A. Fernandes, V.N. Cardoso, R.S. Fernandes, G.P. Oliveira, J.R. Franca, A.A.G. Faraco, M.K. Raizada, and A.J. Ferreira Antiglaucomatous effects of the activation of intrinsic angiotensin-converting enzyme 2 Invest. Ophthalmol. Vis. Sci. 54 2013 4296 4306
96. K. Rigatto, K.R. Casali, V. Shenoy, M.J. Katovich, and M.K. Raizada Diminazene aceturate improves autonomic modulation in pulmonary hypertension Eur. J. Pharmacol. 713 2013 89 93
97. P.K. Haber, M. Ye, J. Wysocki, C. Maier, S.K. Haque, and D. Batlle Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro Hypertension 63 2014 774 782
98. V. Shenoy, A. Gjymishka, Y.P. Jarajapu, Y. Qi, A. Afzal, K. Rigatto, A.J. Ferreira, R.A. Fraga-Silva, P. Kearns, J.Y. Douglas, D. Agarwal, K.K. Mubarak, C. Bradford, W.R. Kennedy, J.Y. Jun, A. Rathinasabapathy, E. Bruce, D. Gupta, A.J. Cardounel, J. Mocco, J.M. Patel, J. Francis, M.B. Grant, M.J. Katovich, and M.K. Raizada Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models Am. J. Respir. Crit. Care Med. 187 2013 648 657
99. Y. Qi, J. Zhang, C.T. Cole-Jeffrey, V. Shenoy, A. Espejo, M. Hanna, C. Song, C.J. Pepine, and M.J. Katovich Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology Hypertension 62 2013 746 752
100. Y. Qiu, P.K. Shil, P. Zhu, H. Yang, A. Verma, B. Lei, and Q. Li Angiotensin-Converting Enzyme 2 (ACE2) Activator Diminazene Aceturate Ameliorates Endotoxin-Induced Uveitis in Mice Invest Ophthalmol Vis Sci 55 2014 3809 3818
101. A.P. Mecca, R.W. Regenhardt, T.E. O'Connor, J.P. Joseph, M.K. Raizada, M.J. Katovich, and C. Sumners Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke Exp Physiol. 96 2011 1084 1096
102. D.C.O. Coutinho, G. Monnerat-Cahli, A.J. Ferreira, and E. Medei Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats Europace 2014 1689 1696
103. R.A. Fraga-Silva, F.P. Costa-Fraga, F. Montecucco, M. Sturny, Y. Faye, F. Mach, G. Pelli, V. Shenoy, R.F. da Silva, M.K. Raizada, R.A.S. Santos, and N. Stergiopulos Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury J. Sex. Med. 12 2015 289 302
104. S. Macêdo, T. Antunes, A.J. Oliveira, A. Guimarães, P.A. Batista, A. Ferreira, and S.S. Sousa Angiotensin converting enzyme 2 activator DIZE modulates metabolic profile in mice decreasing lipogenesis Protein Pept. Lett. 22 2015 332 340
105. S.E. Thatcher, X. Zhang, D.A. Howatt, F. Yiannikouris, S.B. Gurley, T. Ennis, J.A. Curci, A. Daugherty, and L.A. Cassis Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysms Arterioscler. Thromb. Vasc. Biol. 34 2014 2617 2623
106. E. Velkoska, S.K. Patel, K. Griggs, R.J. Pickering, C. Tikellis, and L.M. Burrell Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy PLoS One 10 2015 e0118758
107. M. Neidhart, E. Karouzakis, A. Jüngel, R.E. Gay, and S. Gay Inhibition of spermidine/spermine N1-acetyltransferase activity: a new therapeutic concept in rheumatoid arthritis Arthritis Rheumatol. 66 2014 1723 1733
108. P.R. Libby, and C.W. Porter Inhibition of enzymes of polyamine back-conversion by pentamidine and berenil Biochem. Pharmacol. 44 1992 830 832
109. S. Kuriakose, H. Muleme, C. Onyilagha, E. Okeke, and J.E. Uzonna Diminazene aceturate (Berenil) modulates LPS induced pro-inflammatory cytokine production by inhibiting phosphorylation of MAPKs and STAT proteins Innate Immun. 20 2014 760 773
110. C. Zheng, C. Lei, Z. Chen, S. Zheng, H. Yang, Y. Qiu, and B. Lei Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis Mol. Vis. 21 2015 403 411
111. X. Chen, L. Qiu, M. Li, S. Dürrnagel, B.A. Orser, Z.G. Xiong, and J.F. MacDonald Diarylamidines: High potency inhibitors of acid-sensing ion channels Neuropharmacology 58 2010 1045 1053
112. L.J. Wu, B. Duan, Y.D. Mei, J. Gao, J.G. Chen, M. Zhuo, L. Xu, M. Wu, and T.L. Xu Characterization of acid-sensing ion channels in dorsal horn neurons of rat spinal cord J. Biol. Chem. 279 2004 43716 43724
113. R. Ceglia, L. Chaabane, E. Biffi, A. Bergamaschi, G. Ferrigno, S. Amadio, U. Del Carro, N. Mazzocchi, G. Comi, V. Bianchi, S. Taverna, L. Forti, P. D'Adamo, G. Martino, A. Menegon, and L. Muzio Down-sizing of neuronal network activity and density of presynaptic terminals by pathological acidosis are efficiently prevented by Diminazene Aceturate Brain Behav. Immun. 45 2015 263 276
114. Veterinary compound diminazene aceturate and artemisinin preparation and preparation technology thereof. CN102652753A (2012).
115. Y.K. Goo, M.A. Terkawi, H. Jia, G.O. Aboge, H. Ooka, B. Nelson, S. Kim, F. Sunaga, K. Namikawa, I. Igarashi, Y. Nishikawa, and X. Xuan Artesunate, a potential drug for treatment of Babesia infection Parasitol. Int. 59 2010 481 486
116. A. Iguchi, A. Matsuu, K. Matsuyama, and Y. Hikasa The efficacy of artemisinin, artemether, and lumefantrine against Babesia gibsoni in vitro Parasitol. Int. 64 2015 190 193
117. A.J. Ferreira, D.E.F.G., Foureaux, J.C., Nogueira, N.B., Silva, O.F.G., DE, F.J., Ribeiro, F.A.A., Gomes, D.S.R.A., Souza, D.E.O.C.D. Carvalho, R.M. K. Composições farmacêuticas contendo ativadores do eixo enzima conversora de angiotensina 2/angiotensina- (1-7)/receptor mas para tratamento de patologias oculares. BR102012001875 A2 (2013).
118. V.F.P. Delespaux Antiprotozoal activity of an efflux inhibitor with an anti-protozoal drug, WO2011042565A2 (2011).
119. V.T. Zablotskij, K, Georgiu, V.V.E., Belimenko, P.I. Khristianovskij, A Sarukhanjan. Method of treating babesiasis in dogs, RU2008150401 A (2010).
120. S.S. Gladstone Injectable solution for intramuscular and subcutaneous administration in a vehicle of greater action for bovine affected with babesiosis and anaplasmosis, PI0304738-5 (2006).
121. A.J. Bourdichon Antiprotozoal composition useful for e.G. Treating malaria and sleeping sickness comprises diminazene diaceturate, glycerol and n-methylpyrrolidone, DE 19854139 A1 (2000).
122. A.J. Bourdichon Pharmaceutical composition with trypanocidal properties, WO1997006769 A2 (1997).
123. A.L. Bodley, T.A., Shapiro, M.E. Wall, and M.C. Wani, Inhibition of hemoflagellates by camptothecin compounds, WO1996008249A1 (1996).
124. P.R. Strauss Identification of therapeutic agents effective against infection by members of the parasite family trypanosomatidae, WO1994028162A1 (1994).
125. A.J. Bourdichon Pharmaceutical product, DE4309415 A1 (1994).
126. C.J. Bacchi, R.L., Berens, J.J. Marr, H.C. Nathan, Method for treating african human and veterinary trypanosomiases, US4914086A (1990).
127. D.J. Fluck Liposomes, process for their preparation and compositions containing them, EP0193414 A2 (1986).
128. A. Sjoerdsma, P.P. Mccann, Method of inhibiting the growth of protozoa, CA1174603A1 (1984).
129. F.W. Jennings, Compositions and methods for the treatment of chronic trypanosomiasis infections, US4269830 (1981).
130. M. Coma, P., Aloy, A., Pujol, X., Gomis, B., Oliva, A. Lleó, J.M. Mas, New combination therapies for treating neurological disorders, WO2013061161 A2 (2013).
131. M. Neidhart, S., Gay, Modulators of spermine/spermidine N'-acetyltransferase (SSAT) and SSAT associated proteins for use in prevention or treatment of rheumatoid arthritis, WO 2013083813 A2 (2013).
132. R. Franklin Compositions and methods for treatment of peripheral vascular disease, WO2013119870 A1 (2013).
133. M.K. Raizada, D.A., Ostrov, M.J. Katovich, Method and compositions for treating ACE 2-related disorders, WO2011133966 A2 (2011).
134. X. Jin, D., Macdonald, J., Staunton, A.B. Wilson, Methods and compositions for the treatment of neurodegenerative disorders, WO2008021210 A2 (2008).
135. T. Chow, D., Griller, C. Yeh, and L. Yuen, Inhibitors of endo-exonuclease activity such as pentamidine for the treatment of cancer, WO2001035935 A2 (2001).
136. C.B. Oliveira, L.A. Rigo, R.T. França, L.T. Gressler, L. Dalla Rosa, A.F. Ourique, D.T. Oliveira, R.L. Doyle, K.L.S. d. Moreira, M.L. Veiga, S.T.A. Lopes, R.C.R. Beck, A.S. Da Silva, and S.G. Monteiro Diminazene Aceturate Liposomes: Morphometric and Biochemical Liver, Kidney, and Spleen of Rats Infected with Trypanosoma evansi Pathol. Res. Pract. 210 2014 840 846
137. Y. Shi, X. Zhang, J. Li, Z. Wang, S. Cheng, L. Chen, Y. Qiang, H. Li, and J. Ni Preparation and pharmacokinetics of an injectable thermosensitive hydrogel of diminazene aceturate J. Drug Deliv. Sci. Technol. 23 2013 531 535